UniProt ID | RBM22_HUMAN | |
---|---|---|
UniProt AC | Q9NW64 | |
Protein Name | Pre-mRNA-splicing factor RBM22 | |
Gene Name | RBM22 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 420 | |
Subcellular Localization | Nucleus. Cytoplasm. Mainly located in the nucleus. Translocated from the nucleus to the cytoplasm after heat shock cell treatment. May be shuttling between the nucleus and the cytosol. | |
Protein Description | Involved in the first step of pre-mRNA splicing. Binds directly to the internal stem-loop (ISL) domain of the U6 snRNA and to the pre-mRNA intron near the 5' splice site during the activation and catalytic phases of the spliceosome cycle. Involved in both translocations of the nuclear SLU7 to the cytoplasm and the cytosolic calcium-binding protein PDCD6 to the nucleus upon cellular stress responses.. | |
Protein Sequence | MATSLGSNTYNRQNWEDADFPILCQTCLGENPYIRMTKEKYGKECKICARPFTVFRWCPGVRMRFKKTEVCQTCSKLKNVCQTCLLDLEYGLPIQVRDAGLSFKDDMPKSDVNKEYYTQNMEREISNSDGTRPVGMLGKATSTSDMLLKLARTTPYYKRNRPHICSFWVKGECKRGEECPYRHEKPTDPDDPLADQNIKDRYYGINDPVADKLLKRASTMPRLDPPEDKTITTLYVGGLGDTITETDLRNHFYQFGEIRTITVVQRQQCAFIQFATRQAAEVAAEKSFNKLIVNGRRLNVKWGRSQAARGKEKEKDGTTDSGIKLEPVPGLPGALPPPPAAEEEASANYFNLPPSGPPAVVNIALPPPPGIAPPPPPGFGPHMFHPMGPPPPFMRAPGPIHYPSQDPQRMGAHAGKHSSP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATSLGSNT ------CCCCCCCCC | 13.09 | 22223895 | |
3 | Phosphorylation | -----MATSLGSNTY -----CCCCCCCCCC | 24.16 | 20068231 | |
4 | Phosphorylation | ----MATSLGSNTYN ----CCCCCCCCCCC | 22.61 | 20068231 | |
7 | Phosphorylation | -MATSLGSNTYNRQN -CCCCCCCCCCCCCC | 31.15 | 20873877 | |
9 | Phosphorylation | ATSLGSNTYNRQNWE CCCCCCCCCCCCCCC | 24.70 | 20068231 | |
10 | Phosphorylation | TSLGSNTYNRQNWED CCCCCCCCCCCCCCC | 16.76 | 20068231 | |
26 | Phosphorylation | DFPILCQTCLGENPY CCCCHHHHHCCCCCC | 14.54 | 22210691 | |
33 | Phosphorylation | TCLGENPYIRMTKEK HHCCCCCCEEECHHH | 16.85 | - | |
43 | Ubiquitination | MTKEKYGKECKICAR ECHHHHCCCCCCCCC | 57.77 | 24816145 | |
65 (in isoform 2) | Ubiquitination | - | 7.51 | 21890473 | |
76 | 2-Hydroxyisobutyrylation | EVCQTCSKLKNVCQT HHHHHHHHHHHHHHH | 66.67 | - | |
76 | Acetylation | EVCQTCSKLKNVCQT HHHHHHHHHHHHHHH | 66.67 | 25953088 | |
76 | Ubiquitination | EVCQTCSKLKNVCQT HHHHHHHHHHHHHHH | 66.67 | 33845483 | |
78 | Ubiquitination | CQTCSKLKNVCQTCL HHHHHHHHHHHHHHH | 51.58 | 33845483 | |
83 | Phosphorylation | KLKNVCQTCLLDLEY HHHHHHHHHHHHCCC | 10.45 | 26552605 | |
90 | Phosphorylation | TCLLDLEYGLPIQVR HHHHHCCCCCCEEEE | 31.12 | 28796482 | |
102 | Phosphorylation | QVRDAGLSFKDDMPK EEEECCCCCCCCCCH | 29.36 | 21815630 | |
104 | Ubiquitination | RDAGLSFKDDMPKSD EECCCCCCCCCCHHH | 49.82 | 32015554 | |
109 | Sumoylation | SFKDDMPKSDVNKEY CCCCCCCHHHCCHHH | 53.29 | - | |
109 | Sumoylation | SFKDDMPKSDVNKEY CCCCCCCHHHCCHHH | 53.29 | - | |
109 | Ubiquitination | SFKDDMPKSDVNKEY CCCCCCCHHHCCHHH | 53.29 | 22817900 | |
110 | Phosphorylation | FKDDMPKSDVNKEYY CCCCCCHHHCCHHHH | 40.70 | 25348954 | |
114 | Ubiquitination | MPKSDVNKEYYTQNM CCHHHCCHHHHHHHH | 47.11 | 22817900 | |
114 (in isoform 1) | Ubiquitination | - | 47.11 | 21890473 | |
116 | Phosphorylation | KSDVNKEYYTQNMER HHHCCHHHHHHHHHH | 17.27 | 28796482 | |
117 | Phosphorylation | SDVNKEYYTQNMERE HHCCHHHHHHHHHHH | 11.71 | 28796482 | |
118 | Phosphorylation | DVNKEYYTQNMEREI HCCHHHHHHHHHHHH | 16.74 | 28796482 | |
126 | Phosphorylation | QNMEREISNSDGTRP HHHHHHHCCCCCCCC | 26.06 | 20068231 | |
126 | O-linked_Glycosylation | QNMEREISNSDGTRP HHHHHHHCCCCCCCC | 26.06 | 30379171 | |
128 | Phosphorylation | MEREISNSDGTRPVG HHHHHCCCCCCCCCC | 30.54 | 20068231 | |
131 | Phosphorylation | EISNSDGTRPVGMLG HHCCCCCCCCCCCCE | 36.47 | 20068231 | |
136 | Sulfoxidation | DGTRPVGMLGKATST CCCCCCCCCEEEECH | 4.55 | 21406390 | |
139 | Sumoylation | RPVGMLGKATSTSDM CCCCCCEEEECHHHH | 44.52 | 28112733 | |
139 | Ubiquitination | RPVGMLGKATSTSDM CCCCCCEEEECHHHH | 44.52 | 29967540 | |
139 | Methylation | RPVGMLGKATSTSDM CCCCCCEEEECHHHH | 44.52 | 30792361 | |
141 | Phosphorylation | VGMLGKATSTSDMLL CCCCEEEECHHHHHH | 35.70 | 23403867 | |
142 | Phosphorylation | GMLGKATSTSDMLLK CCCEEEECHHHHHHH | 30.67 | 23401153 | |
143 | Phosphorylation | MLGKATSTSDMLLKL CCEEEECHHHHHHHH | 25.13 | 23898821 | |
144 | Phosphorylation | LGKATSTSDMLLKLA CEEEECHHHHHHHHH | 22.31 | 23403867 | |
149 | Ubiquitination | STSDMLLKLARTTPY CHHHHHHHHHHCCCH | 35.82 | 32015554 | |
149 | Sumoylation | STSDMLLKLARTTPY CHHHHHHHHHHCCCH | 35.82 | 25218447 | |
149 | Sumoylation | STSDMLLKLARTTPY CHHHHHHHHHHCCCH | 35.82 | - | |
149 | Methylation | STSDMLLKLARTTPY CHHHHHHHHHHCCCH | 35.82 | 82987753 | |
154 | Phosphorylation | LLKLARTTPYYKRNR HHHHHHCCCHHHCCC | 12.07 | 21815630 | |
156 | Phosphorylation | KLARTTPYYKRNRPH HHHHCCCHHHCCCCC | 21.37 | 22817900 | |
157 | Phosphorylation | LARTTPYYKRNRPHI HHHCCCHHHCCCCCC | 12.50 | 22817900 | |
163 (in isoform 2) | Ubiquitination | - | 30.37 | 21890473 | |
170 | Ubiquitination | HICSFWVKGECKRGE CCCEEEECCCCCCCC | 39.32 | - | |
185 | Methylation | ECPYRHEKPTDPDDP CCCCCCCCCCCCCCC | 47.28 | 116265247 | |
199 | Ubiquitination | PLADQNIKDRYYGIN CCCCCCHHHHHCCCC | 43.64 | 33845483 | |
202 | Phosphorylation | DQNIKDRYYGINDPV CCCHHHHHCCCCCHH | 19.04 | 27642862 | |
203 | Phosphorylation | QNIKDRYYGINDPVA CCHHHHHCCCCCHHH | 16.66 | 27642862 | |
212 | Ubiquitination | INDPVADKLLKRAST CCCHHHHHHHHHHCC | 46.08 | 21890473 | |
212 | Acetylation | INDPVADKLLKRAST CCCHHHHHHHHHHCC | 46.08 | 19608861 | |
212 (in isoform 1) | Ubiquitination | - | 46.08 | 21890473 | |
219 | Phosphorylation | KLLKRASTMPRLDPP HHHHHHCCCCCCCCC | 30.15 | 28555341 | |
286 | Acetylation | AAEVAAEKSFNKLIV HHHHHHHHHCCEEEE | 56.47 | 25953088 | |
286 | Ubiquitination | AAEVAAEKSFNKLIV HHHHHHHHHCCEEEE | 56.47 | - | |
290 | Sumoylation | AAEKSFNKLIVNGRR HHHHHCCEEEECCEE | 37.26 | 25218447 | |
290 | Acetylation | AAEKSFNKLIVNGRR HHHHHCCEEEECCEE | 37.26 | 25953088 | |
290 | Sumoylation | AAEKSFNKLIVNGRR HHHHHCCEEEECCEE | 37.26 | - | |
324 | Sumoylation | GTTDSGIKLEPVPGL CCCCCCCEEEECCCC | 50.77 | - | |
395 | Methylation | GPPPPFMRAPGPIHY CCCCCCCCCCCCCCC | 37.70 | 30763003 | |
395 | Dimethylation | GPPPPFMRAPGPIHY CCCCCCCCCCCCCCC | 37.70 | - | |
404 | Phosphorylation | PGPIHYPSQDPQRMG CCCCCCCCCCHHHCC | 39.80 | - | |
418 | Phosphorylation | GAHAGKHSSP----- CCCCCCCCCC----- | 48.03 | 26270265 | |
419 | Phosphorylation | AHAGKHSSP------ CCCCCCCCC------ | 34.06 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RBM22_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RBM22_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RBM22_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AQR_HUMAN | AQR | physical | 22365833 | |
HNRL1_HUMAN | HNRNPUL1 | physical | 22365833 | |
RBM4_HUMAN | RBM4 | physical | 22365833 | |
RFOX2_HUMAN | RBFOX2 | physical | 22365833 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-212, AND MASS SPECTROMETRY. |